Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arno

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Cancer|October 1, 1973
Sinus histiocytosis with massive lymphadenopathy--properties of cultured histiocytesA Karpas, J Arno, J Cawley
Environmental Science & Technology|December 24, 2011
Acetone conversion in a low-pressure oxygen surface wave plasmaJ Arno, J W Bevan, M Moisan
Journal of Clinical Pathology|November 1, 1974
Proceedings: The development of myelomatosis in a case of existing Hodgkin's diseaseJ C Cawley, A H Goldstone, J Arno
Journal of Clinical Pathology|February 3, 2000
Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34E Astall, H Yarranton, J Arno, et al.
Oncogene|June 1, 1993
Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary glandJ M Bradbury, J Arno, P A Edwards
British Journal of Haematology|June 1, 1980
Sinus histiocytosis with massive lymphadenopathy: virological, immunological and morphological studiesA Karpas, C Worman, J Arno, et al.
Human Immunology|September 1, 1985
Polymorphic radiation sensitivity of human natural killer activity: possible role of DNA strand breakageB Schacter, S Hansal, J Arno, et al.
Postgraduate Medical Journal|June 1, 1985
Breast lumps and lymphomaM Ellis, J Arno, M Owen-Smith, et al.
Molecular Pharmacology|November 10, 2006
Genomic screening in vivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatinChunyan Liao, Bin Hu, Matthew J Arno, et al.
Leukemia Research|October 5, 2002
Analysis of CHK2 in patients with myelodysplastic syndromesDilek Aktas, Matthew J Arno, Feyruz Rassool, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Cancer|October 1, 1973
Sinus histiocytosis with massive lymphadenopathy--properties of cultured histiocytesA Karpas, J Arno, J Cawley
Environmental Science & Technology|December 24, 2011
Acetone conversion in a low-pressure oxygen surface wave plasmaJ Arno, J W Bevan, M Moisan
Journal of Clinical Pathology|November 1, 1974
Proceedings: The development of myelomatosis in a case of existing Hodgkin's diseaseJ C Cawley, A H Goldstone, J Arno
Journal of Clinical Pathology|February 3, 2000
Granulocytic sarcoma preceding AML M0 and the diagnostic value of CD34E Astall, H Yarranton, J Arno, et al.
Oncogene|June 1, 1993
Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary glandJ M Bradbury, J Arno, P A Edwards
British Journal of Haematology|June 1, 1980
Sinus histiocytosis with massive lymphadenopathy: virological, immunological and morphological studiesA Karpas, C Worman, J Arno, et al.
Human Immunology|September 1, 1985
Polymorphic radiation sensitivity of human natural killer activity: possible role of DNA strand breakageB Schacter, S Hansal, J Arno, et al.
Postgraduate Medical Journal|June 1, 1985
Breast lumps and lymphomaM Ellis, J Arno, M Owen-Smith, et al.
Molecular Pharmacology|November 10, 2006
Genomic screening in vivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatinChunyan Liao, Bin Hu, Matthew J Arno, et al.
Leukemia Research|October 5, 2002
Analysis of CHK2 in patients with myelodysplastic syndromesDilek Aktas, Matthew J Arno, Feyruz Rassool, et al.
Pageof 3